SCHEMBL209179

SCHEMBL209179

CC(C)(C)OC(=O)ON1CCC(c2nc(-c3ccccc3)c(-c3ccccc3)o2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 7/20 0.46
RXRA P19793 5/20 0.46
RXRB P28702 5/20 0.46
RXRG P48443 4/20 0.46
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
PTGIR P43119 3/20 0.40
GAA P10253 1/20 0.40
THRB P10828 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CKS1B P61024 3/20 0.39
SKP1 P63208 3/20 0.39
SKP2 Q13309 3/20 0.39
RARA P10276 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
FAAH O00519 2/20 0.38
HTR2B P41595 1/20 0.38
NR4A1 P22736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27811555 0.90 NR4A2 (0.48) NR4A2RXRARXRBRXRGKDM4E
SCHEMBL558040 0.85 SMN1; SMN2 (0.55) NR4A2RXRARXRBRXRGKDM4E
SCHEMBL3102619 0.80 SMN1; SMN2 (0.50) GAATHRBSMN1; SMN2CKS1BSKP1
SCHEMBL3104584 0.74 HTT (0.56) KDM4EALDH1A1LMNAGAATHRB
SCHEMBL13157594 0.74 NR4A2 (0.49) NR4A2RXRARXRBRXRGKDM4E
SCHEMBL8056798 0.73 SMN1; SMN2 (0.47) KDM4EGAATHRBSMN1; SMN2CKS1B
SCHEMBL7915792 0.73 SMN1; SMN2 (0.47) KDM4EGAATHRBSMN1; SMN2CKS1B
SCHEMBL6167533 0.72 HPGDS (0.41) KDM4EALDH1A1CKS1BSKP1SKP2
SCHEMBL16245080 0.71 POLB (0.48) NR4A2RXRARXRBRXRGKDM4E
SCHEMBL10266215 0.71 NR4A2 (0.47) NR4A2RXRARXRBRXRGKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2400962-B1 Medicinal combinations containing PDE4 inhibitors and NSAIDS BOEHRINGER INGELHEIM INT (DE) 2017-11-08 EP disclosed
EP-2555774-B1 Medicine combinations containing pde4 inhibitors and ep4 receptor antagonists BOEHRINGER INGELHEIM INT (DE) 2015-10-21 EP disclosed
EP-2610258-B1 Substituted piperidino dihydrothieno pyrimidines BOEHRINGER INGELHEIM INT (DE) 2014-08-27 EP disclosed
EP-2380891-B1 Substituted piperidino-dihydrothienopyrimidines BOEHRINGER INGELHEIM INT (DE) 2013-12-11 EP disclosed
EP-2610258-A1 Substituted piperidino dihydrothieno pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-07-03 EP disclosed
EP-2215092-B1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES BOEHRINGER INGELHEIM INT (DE) 2012-01-25 EP disclosed
EP-2400962-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
EP-2380891-A1 Substituted piperidino-dihydrothienopyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-26 EP disclosed
WO-2010097334-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
EP-2215092-A1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES Boehringer Ingelheim International GmbH (DE) 2010-08-11 EP disclosed
WO-2009050248-A1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed